B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion (original) (raw)
Chambers, C.A. & Allison, J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol.9, 369– 404 (1997). Article Google Scholar
Lenschow, D.J., Walunas, T.L. & Bluestone, J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol.14, 233–258 (1996). ArticleCAS Google Scholar
Chen, L., Linsley, P.S. & Hellstrom, K.E. Costimulation of T cells for tumor immunity. Immunol. Today14, 483–486 (1993). ArticleCAS Google Scholar
Boise, L.H., Noel, P.J. & Thompson, C.B. CD28 and apoptosis. Curr. Opin. Immunol.7, 620–625 (1995). ArticleCAS Google Scholar
Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med.183, 2533– 2540 (1996). ArticleCAS Google Scholar
Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med.183, 2541– 2550 (1996). ArticleCAS Google Scholar
Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature397, 263–266 (1999). ArticleCAS Google Scholar
Freeman, G.J. et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science262, 909–911 (1993). ArticleCAS Google Scholar
Azuma, M. et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature366, 76–79 (1993). ArticleCAS Google Scholar
Peach, R.J. et al. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptor CTLA-4 and CD28. J. Biol. Chem.270, 21181–21187 (1995). ArticleCAS Google Scholar
Fargeas, C.A. et al. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA-4. J. Exp. Med.182, 667–675 (1995). ArticleCAS Google Scholar
Bajorath, J., Peach, R. J. & Linsley, P. S. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci.3, 2148– 2150 (1994). ArticleCAS Google Scholar
Linsley, P.S. et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity1, 793–801 (1994). ArticleCAS Google Scholar
Inaba, K. et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro . J. Exp. Med.180, 1849– 1860 (1994). ArticleCAS Google Scholar
Freeman, G. J. et al. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity2, 523– 532 (1995). ArticleCAS Google Scholar
Nakajima, A. et al. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol.9, 637–644 (1997). ArticleCAS Google Scholar
Schwartz, R. H. T cell clonal anergy. Curr. Opin. Immunol.9, 351–357 (1997). ArticleCAS Google Scholar
Georgescu, L, Vakkalanka, R.K, Elkon, K.B. & Crow, M.K. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest.100, 2622 –2633 (1997). ArticleCAS Google Scholar
Goerdt, S. & Orfanos, C. E. Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity10, 137–142 (1999). ArticleCAS Google Scholar
Li, Y., McGowan, P., Hellstrom, K.E. & Chen, L. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J. Immunol.153, 421–428 (1994). CASPubMed Google Scholar
Chen, L. et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell71, 1093–1102 (1992). ArticleCAS Google Scholar
Li, Y., Hellstrom, K.E., Newby, S.A. & Chen, L. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J. Exp. Med.183, 639–644 (1996). ArticleCAS Google Scholar